Archive results
Sort by

92nd General Session of the World Assembly of Delegates
The 92nd General Session of the World Assembly of Delegates is scheduled from Sunday, 25 to Thursday, 29 May 2025, at the Maison de La Chimie in Paris, France. This invitation-only event will convene 183 WOAH Members and representatives from international organisations who have signed an official agreement with WOAH. The 92nd General Session will also bring…

STAR IDAZ will attend the 92nd General Session of the World Assembly of Delegates
The 92nd General Session of the World Assembly of Delegates will take place at the Maison de La Chimie in Paris, France from 25 to 29 May, and STAR IDAZ is delighted to be attending. This invitation-only event will convene 183 WOAH Members and representatives from international organizations who have signed an official agreement with…

Investing in One Health
STAR IDAZ IRC held a One Health funding workshop on 12-13th March 2025 in Nairobi, Kenya. The event built on the excellent work of the One Health Working Group to date, including a survey, a series of workshops and the Mapping One Health: An exploration of the global funding landscape for One Health research report. …

Ceva and ILRI Partner to launch Animal Health Innovation Hub for Africa
The International Livestock Research Institute (ILRI) and Ceva Santé Animale (Ceva) have signed a Memorandum of Understanding (MoU) to create a ground-breaking Animal Health Innovation Hub at ILRI’s Nairobi campus.

One Health awareness month
At STAR IDAZ IRC, our One Health Working Group has been busy working on how to improve and better utilise existing funding mechanisms for research that embeds a One Health approach. The One Health Working Group members include expertise across human health, animal health, plant health, health of the environment and social sciences. Since 2022,…

Modified live vaccine protects against bovine anaplasmosis
Bovine anaplasmosis caused by Anaplasma marginale is an economically important tick-borne disease of cattle in tropical and subtropical regions throughout the world. Killed vaccines have been used for control of this disease with limited success. To create a novel vaccine, a team led by Roman Ganta genetically modified A. marginale by targeted gene deletion method.…